ATENOLOL

USDailyMed:Atenolol AU:C C07AB03(WHO) AU:S4(Prescription only)US:℞-onlyIn general: ℞ (Prescription only) (RS)-2-{4-[2-Hydroxy-3-(propan-2-ylamino)propoxy]phenyl}acetamide 29122-68-7 2249 548 DB00335 2162 50VV3VW0TI D00235 CHEBI:2904 ChEMBL24 DTXSID2022628 Interactive image O=C(N)Cc1ccc(cc1)OCC(O)CNC(C)C InChI=1S/C14H22N2O3/c1-10(2)16-8-12(17)9-19-13-5-3-11(4-6-13)7-14(15)18/h3-6,10,12,16-17H,7-9H2,1-2H3,(H2,15,18)Key:METKIMKYRPQLGS-UHFFFAOYSA-N Atenololis abeta blockermedication primarily used to treathigh bloo‍‍‍‍‍‍​​​‍​​​​​​d pressureandheart-associated chest pain.Although used to treat high blood pressure, it does not seem to improvemortalityin those with the condition.Other uses include the prevention ofmigrainesand treatment of certainirregular heart beats.It is takenorally(by mouth) or byintravenous injection(injection into a vein).It can also be used with otherblood pressure medications. Commonside effectsincludefeeling tired,heart failure,dizziness,depression, andshortness of breath.Other serious side effects includebronchial spasm.Use is not recommended duringpregnancyand alternative drugs are preferred whenbreastfeeding.It works by blockingβ1-adrenergic receptorsin theheart, thus decreasingheart rate,force of heart beats, andblood pressure. Atenolol was patented in 1969 and approved for medical use in 1975.It is on theWorld Health Organization's List of Essential Medicines.It is available as ageneric medication.In 2023, it was the 75th most commonly prescribed medication in the United States, with more than 9million prescriptions.